News25/Ratings6
News · 26 weeks22+150%
2026-03-012026-08-23
Mix1390d
- SEC Filings4(31%)
- Insider4(31%)
- Earnings2(15%)
- Other2(15%)
- Analyst1(8%)
Latest news
25 items- SECSEC Form EFFECT filed by Carlsmed Inc.EFFECT - CARLSMED, INC. (0001794546) (Filer)
- SECSEC Form 10-Q filed by Carlsmed Inc.10-Q - CARLSMED, INC. (0001794546) (Filer)
- SECCarlsmed Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits8-K - CARLSMED, INC. (0001794546) (Filer)
- PRCarlsmed® Reports Second Quarter 2026 Financial Results and Raises Full-Year GuidanceSecond quarter 2026 revenue of $18.9 million, representing 57% growth year-over-year Full year 2026 revenue guidance raised to $74 million to $78 million CARLSBAD, Calif., Aug. 05, 2026 (GLOBE NEWSWIRE) -- Carlsmed, Inc. (NASDAQ:CARL) ("Carlsmed" or the "Company"), a medical technology company pioneering AI-enabled personalized spine surgery solutions, today reported financial results for the second quarter ended June 30, 2026. "Our second quarter 2026 results reflect the growing momentum of aprevo® procedures and further progress on our path to profitability," said Mike Cordonnier, Chairman and Chief Executive Officer. "We delivered 57% revenue growth year-over-year, expanded gross mar
- PRCarlsmed Announces Favorable Reimbursement for aprevo® lumbar ProceduresCARLSBAD, Calif., Aug. 03, 2026 (GLOBE NEWSWIRE) -- Carlsmed, Inc. (NASDAQ:CARL) ("Carlsmed" or the "Company"), a medical technology company pioneering AI-enabled personalized spine surgery solutions, today announced that the Centers for Medicare & Medicaid Services (CMS) has finalized a favorable reimbursement policy applicable to inpatient aprevo® Lumbar spinal fusion procedures in the Hospital Inpatient Prospective Payment System (IPPS) Final Rule for fiscal year 2027 (FY27). The new MS-DRG assignments and payment rates will go into effect on October 1, 2026. In the FY27 IPPS Final Rule, CMS addressed Carlsmed’s request and reassigned aprevo® Lumbar fusion procedures to three newly cre
- PRCarlsmed, Inc. To Participate in Upcoming Investor ConferencesCARLSBAD, Calif., July 27, 2026 (GLOBE NEWSWIRE) -- Carlsmed, Inc. (NASDAQ:CARL) ("Carlsmed" or the "Company"), a medical technology company pioneering AI-enabled personalized spine surgery solutions today announced that management will participate in the following investor conferences: 11th Annual Needham Virtual MedTech & Diagnostics 1x1 Conference. The Company will host one-on-one meetings on Monday, August 10, 2026.Bank of America SMID Cap Virtual Conference. Fireside chat on Wednesday, August 12, 2026, at 11:00 AM ET. A live webcast will be available to registered participants. Investors interested in participating in virtual one-on-one meetings should contact their Bank of America r
- PRCarlsmed Inc. to Report Second Quarter 2026 Financial Results on August 5, 2026CARLSBAD, Calif., July 22, 2026 (GLOBE NEWSWIRE) -- Carlsmed, Inc. (NASDAQ:CARL) ("Carlsmed" or the "Company"), a medical technology company pioneering AI-enabled personalized spine surgery solutions, today announced it will report its second quarter 2026 financial results after market close on Wednesday, August 5, 2026. Management will also host a conference call and concurrent webcast starting at 1:30 PM Pacific Time. A live webcast of the conference call will be available in the Events & Presentations section of the company’s investor website at investors.carlsmed.com. Participants may also join via telephone by registering here. A replay will be archived on the company’s website follo
- ANALYSTNeedham initiated coverage on Carlsmed with a new price targetNeedham initiated coverage of Carlsmed with a rating of Buy and set a new price target of $17.00
- INSIDERDirector Oboyle Kevin C was granted 13,698 shares, increasing direct ownership by 79% to 31,031 units (SEC Form 4)4 - CARLSMED, INC. (0001794546) (Issuer)
- INSIDERDirector Sidow Kevin was granted 13,698 shares, increasing direct ownership by 23% to 73,264 units (SEC Form 4)4 - CARLSMED, INC. (0001794546) (Issuer)
- INSIDERDirector Young Philip M was granted 13,698 shares, increasing direct ownership by 79% to 31,031 units (SEC Form 4)4 - CARLSMED, INC. (0001794546) (Issuer)
- INSIDERDirector Root Jonathan D was granted 13,698 shares, increasing direct ownership by 3% to 497,697 units (SEC Form 4)4 - CARLSMED, INC. (0001794546) (Issuer)
- SECCarlsmed Inc. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders8-K - CARLSMED, INC. (0001794546) (Filer)
- SECSEC Form 10-Q filed by Carlsmed Inc.10-Q - CARLSMED, INC. (0001794546) (Filer)
- SECCarlsmed Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits8-K - CARLSMED, INC. (0001794546) (Filer)
- PRCarlsmed® Reports First Quarter 2026 Financial ResultsFirst quarter 2026 revenue of $16.1 million, representing 58% growth year-over-year Full year 2026 revenue guidance raised to $72 million to $77 million CARLSBAD, Calif., May 05, 2026 (GLOBE NEWSWIRE) -- Carlsmed, Inc. (NASDAQ:CARL) ("Carlsmed" or the "Company"), a medical technology company pioneering AI-enabled personalized spine surgery solutions, today reported financial results for the first quarter ended March 31, 2026. "We began 2026 with strong momentum, delivering 58% year-over-year revenue growth, publishing meaningful clinical data, and debuting new products to continue to advance our mission of improved patient outcomes and reduced cost of healthcare," said Mike Cordonnier,
- PRCarlsmed, Inc. To Participate in Upcoming Investor ConferencesCARLSBAD, Calif., April 28, 2026 (GLOBE NEWSWIRE) -- Carlsmed, Inc. (NASDAQ:CARL) ("Carlsmed" or the "Company"), today announced that Mike Cordonnier, Chairman and Chief Executive Officer, will participate in the following investor conferences. Bank of America Global Healthcare Conference in Las Vegas, NV. Fireside chat on Tuesday, May 12, 2026, at 4:20 PM PT. A live webcast will be available to registered participants, and management will host one-on-one meetings on the same day.Jefferies Global Healthcare Conference in New York, NY. The Company will host one-on-one meetings on Thursday, June 4, 2026.Goldman Sachs 47th Annual Global Healthcare Conference in Miami Beach, FL. Fireside cha
- SECSEC Form DEFA14A filed by Carlsmed Inc.DEFA14A - CARLSMED, INC. (0001794546) (Filer)
- SECSEC Form DEF 14A filed by Carlsmed Inc.DEF 14A - CARLSMED, INC. (0001794546) (Filer)
- PRCarlsmed Inc. to Report First Quarter 2026 Financial Results on May 5, 2026CARLSBAD, Calif., April 14, 2026 (GLOBE NEWSWIRE) -- Carlsmed, Inc. (NASDAQ:CARL), a medical technology company pioneering AI-enabled personalized spine surgery solutions, today announced it will report its first quarter 2026 financial results after market close on Tuesday, May 5, 2026. Management will also host a conference call and concurrent webcast starting at 1:30 PM Pacific Time. Conference Call Information To participate in this event, dial in approximately 5 to 10 minutes before the start of the conference call. Event Date: Tuesday, May 5, 2026Time: 1:30 PM Pacific Time Participant Registration: https://register-conf.media-server.com/register/BI34a01ff77922411f8b9d41f912e4159b
- PRCarlsmed, Inc. To Participate in the 25th Annual Needham Virtual ConferenceCARLSBAD, Calif., April 01, 2026 (GLOBE NEWSWIRE) -- Carlsmed, Inc. (NASDAQ:CARL) ("Carlsmed" or the "Company"), today announced that Mike Cordonnier, CEO and Chairman, will be presenting at the 25th Annual Needham Virtual Conference on April 13, 2026 at 11:45 AM ET. A live webcast will be available to registered participants. Following the presentation, the webcast replay will be available at https://event.summitcast.com/view/cCMfZsH5ZqrwSNTwfC9JDv/RczDxtnmshQKpi2ivHQcH3 About Carlsmed, Inc. Carlsmed is a medical technology company pioneering AI-enabled personalized spine surgery solutions with a mission to improve outcomes and decrease the cost of healthcare for spine surgery and bey
- INSIDERCEO, President Cordonnier Michael exercised 391,686 shares at a strike of $0.68 and sold $2,629,889 worth of shares (197,855 units at $13.29), increasing direct ownership by 14% to 1,550,477 units (SEC Form 4)4 - CARLSMED, INC. (0001794546) (Issuer)
- SECSEC Form S-8 filed by Carlsmed Inc.S-8 - CARLSMED, INC. (0001794546) (Filer)
- SECSEC Form 10-K filed by Carlsmed Inc.10-K - CARLSMED, INC. (0001794546) (Filer)
- PRCarlsmed® Reports Fourth Quarter and Full Year 2025 Financial ResultsFourth quarter revenue of $15.2 million; 61% growth YoY Full year revenue of $50.5 million; 86% growth YoY CARLSBAD, Calif., Feb. 25, 2026 (GLOBE NEWSWIRE) -- Carlsmed, Inc. (NASDAQ:CARL) ("Carlsmed" or the "Company"), a medical technology company pioneering AI-enabled personalized spine surgery solutions, today reported financial results for the fourth quarter and full year ended December 31, 2025. "We delivered another very strong quarter with 61% revenue growth year-over-year, gross margin expansion to 76.5%, and reduction of our lead times to within six business days. These achievements demonstrate our momentum and the speed at which we are scaling while maintaining our culture o
CARL FAQ
6 questionsWhere does CARL stock trade?
Carlsmed Inc. (CARL) is listed on NASDAQ.What sector and industry is CARL in?
Carlsmed Inc. operates in the Health Care sector, Medical/Dental Instruments industry.When did Carlsmed Inc. go public?
Carlsmed Inc. (CARL) completed its IPO in 2025.What are analysts saying about CARL?
Carlsmed Inc. has had 6 recent analyst actions on file. The most recent action was from Needham: Buy with a $1700.00 price target on 2026-07-01. Recent price targets range from $1600.00 to $2100.00.What companies are similar to CARL?
Notable peers in the same industry include SYK (Stryker Corporation), MMM (3M Company), BSX (Boston Scientific Corporation), BDX (Becton Dickinson and Company), MDLN (Medline Inc.). Compare CARL side-by-side with any of them on Quantisnow.How can I track CARL on Quantisnow?
Quantisnow aggregates Carlsmed Inc.'s SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow CARL to receive live email and push alerts on every new disclosure.